Client News

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed’s entry into the European cosmetics market

2024 Full Year Results

Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women

AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development

iOmx Therapeutics Receives Regulatory Approval of Clinical Trial Application for IOMX 0675

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics